Modular Finance AbModular Finance Ab

Physitrack Plc announces deal with European insurer to launch consumer-facing self-management product

Refinitiv1 minuto di lettura

First phase of agreement generates €55,000 of upfront and €24,000 annual recurring revenue, strengthens Physitrack’s presence in direct to consumer offering.

London, UK – September 25, 2025 – Physitrack Plc (Nasdaq First North Premier: PTRK) today announced an agreement with one of the largest insurers in mainland Europe to launch a new consumer-facing self-management and self-triage application for musculoskeletal (MSK) conditions. The first phase of the agreement is valued at €55,000 upfront with an annual recurring subscription fee of €24,000, with revenue recognition expected to commence in the third quarter of 2025. Subsequent phases of the agreement, with additional revenue generation and expanded scope of delivery, commence in Q4 2025 and Q1 2026 respectively.

The solution will enable the insurer’s plan members to proactively screen themselves for MSK-related issues and receive guided escalation either to self-management through Physitrack’s exercise library and patient engagement suite, or directly to physiotherapy care when clinically appropriate.

This agreement builds on a long-standing relationship between Physitrack and the insurer, reflecting a shared commitment to empowering patients to take control of their care journey while supporting the insurer in optimising clinical workflows, enhancing patient satisfaction, and managing costs related to physiotherapy.

“We are proud to extend our collaboration with this major European insurer,” said Henrik Molin, CEO and Founder of Physitrack Plc. “It has been a pleasure to evolve our technology together over the years, and this next step brings plan members greater freedom to access the right care at the right time—whether that means self-care or professional physiotherapy support.”

A Spotlight interview segment with CEO and Founder Henrik Molin can be found here:

https://vimeo.com/1117035938/a0eb7ad5ea

Accedi o crea un account gratuito per leggere queste notizie